DHDaniel Herr

Daniel Herr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniel Herr has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • C. Keck

    Department of Obstetrics and Gynecology, Freiburg University Medical Center, Freiburg, Germany

    2 shared publications
  • Christine Wulff

    Department of Obstetrics and GynecologyUniversity of Würzburg, Josef-Schneider-Str. 4, 97080 Würzburg, GermanyDepartment of Obstetrics and GynecologyUlm University Medical Centre, Ulm, Germany

    2 shared publications
  • H. Bettendorf

    Department of Obstetrics and Gynecology, Freiburg University Medical Center, Freiburg, Germany

    2 shared publications
  • I. Bekes

    Frauenklinik, Universitätsklinikum Ulm, Ulm

    2 shared publications
  • R. Kreienberg

    Universitätsfrauenklinik Ulm, Ulm, Deutschland

    2 shared publications
  • A. Rakenius

    Department of Obstetrics and Gynecology, Freiburg University Medical Center, Freiburg, Germany

    1 shared publication

Latest Publications

  • Regulation of endothelial permeability in the primate corpora lutea: implications for ovarian hyperstimulation syndrome

    by Daniel Herr, Inga Bekes, Christine Wulff

    In a developing human corpus luteum, a closely regulated cellular communication system exists between the luteal steroidogenic cells and endothelial cells. This system guaranties the vascularization process during luteal formation. The process is combined with rapid release of large amounts of progesterone into the bloodstream. The regulation of endothelial proliferation and permeability by LH and human chorionic gonadotropin (hCG) is integral to this process. On the cellular level, endothelial permeability is regulated by intercellular junctions, such as adherens junctions (AJ) and tight junctions (TJ), which act as zipper-like structures between interacting endothelial cells. Several cell junctional proteins are localized to the corpus luteum, including Occludin, Nectin 2, Claudin 1, and Claudin 5, as well as, vascular endothelial (VE)-Cadherin. It has been assumed that regulation of AJ- and TJ-proteins is of particular importance for permeability, and accordingly, for the functionality of the corpus luteum in early pregnancy, because treatment with hCG induces downregulation of juntional proteins in the luteal vessels. The effect of hCG on the adhesive molecules is mediated by VE growth factor (VEGF). On a functional level, the hCG-dependent and VEGF-mediated decrease in junctional proteins causes a decrease in the density of cell–cell closure and, accordingly, an increase in endothelial permeability. In doing so, the different junctional proteins are not only directly influenced by VEGF but also interact among themselves and influence each other reciprocally. Disturbances in this strictly, regulated interactions may explain the development of pathologies with increased vascular permeability, such as the ovarian hyperstimulation syndrome.


  • Open Access

    Therapy for Primary Vulvar Carcinoma

    by D. Herr, I. Juhasz-Boess, E. F. Solomayer

    The rather rare vulvar cancer is almost always a squamous cell carcinoma that mostly develops from an underlying VIN or HPV infection. In addition, lichen sclerosus et atrophicans, immune deficiency, nicotine abuse or anogenital intraepithelial neoplasias may play a role in the pathogenesis. Surgical therapy aims at an R0 resection in the sense of a complete vulvectomy or a radical local excision with, if necessary, plastic reconstruction. Also, the vulvar field resection with consideration of the compartment model has been discussed. Besides the classic inguinofemoral lymphadenectomy, in selected cases of vulvar cancer sentinel biopsies are performed by experienced surgeons in the larger centres. In contrast, systemic therapy plays only a subordinate role; in isolated cases down-staging by means of neoadjuvant chemotherapy may be useful. However, there is at present no indication for adjuvant chemotherapy. Neoadjuvant radiochemotherapy is also not to be recommended on account of its unfavourable ratio of efficacy to side effects. On the other hand adjuvant radiotherapy is indicated in cases of positive inguinal lymph nodes. According to the current data the indication should be made generously in such cases. Das eher seltene Vulvakarzinom ist fast immer ein Plattenepithelkarzinom, das meist auf dem Boden einer vulvären intraepithelialen Neoplasie (VIN) oder einer HPV-Infektion entsteht. Daneben sind auch der Lichen sclerosus et atrophicans, eine Immundefizienz, Nikotinabusus oder anogenitale intraepitheliale Neoplasien an der Pathogenese beteiligt. Die operative Therapie zielt auf eine R0-Resektion im Sinne einer kompletten Vulvektomie oder einer radikalen lokalen Exzision ggf. mit plastischer Rekonstruktion. Daneben wird zunehmend auch die Vulvafeldresektion unter Berücksichtigung des Kompartment-Modells diskutiert. Neben der klassischen inguinofemoralen Lymphonodektomie wird auch beim Vulvakarzinom die Sentinel-Biopsie in größeren Zentren und ausgewählten Situationen von erfahrenen Operateuren durchgeführt. Die Systemtherapie spielt dagegen eine nur untergeordnete Rolle; in Einzelfällen kann ein Downstaging durch eine neoadjuvante Chemotherapie sinnvoll sein. Für eine adjuvante Chemotherapie gibt es derzeit keine Indikation. Ebenfalls sollte eine neoadjuvante Radiochemotherapie aufgrund der ungünstigen Ratio an Effektivität und Nebenwirkungen vermieden werden. Im Gegensatz dazu ist eine adjuvante Bestrahlung aber bei positiven inguinalen Lymphknoten indiziert. Hierzu sollte die Indikation nach aktuellen Daten großzügig gestellt werden.


  • Regulation of Endothelial Permeability in the Corpus Luteum: A Review of the Literature

    by D. Herr, I. Bekes, C. Wulff

    The development of the human corpus luteum (yellow body) is dictated by a strictly controlled system of mutually communicating cells, the luteal steroid hormone-producing cells and endothelial cells. This cell-to-cell communication facilitates control of neoangiogenesis which is a prerequisite for the development of the corpus luteum and its function, the rapid release of large amounts of progesterone into the blood-vascular system. Preconditions for this process are the hormonal regulation of endothelial cell proliferation as well as of vascular permeability through LH and hCG. The morphological correlates of endothelial permeability are cell-to-cell adhesion molecules such as adherens junctions (AJ) and tight junctions (TJ) that open and close the gaps between mutually interacting, neighbouring endothelial cells like a “zip fastener”. Various types of cell adhesion molecules have been detected in the corpus luteum such as occludin, claudin 1 and claudin 5 as well as VE-cadherin. It may be assumed that the regulation of AJ and TJ proteins is of particular importance for the permeability and thus for the function of the corpus luteum in early pregnancy since hCG treatment leads to a down-regulation of cell adhesion molecules in the luteal vessels. This effect is apparently mediated by VEGF. From a functional point of view, the hCG-dependent and VEGF-mediated down-regulation of cell adhesion molecules leads to a reduced transmissibility of cell-to-cell contacts and thus to an increased endothelial permeability. In this process the various cell adhesion molecules are not only directly regulated by VEGF but they also mutually interact and thus influence one another. Die Entwicklung des humanen Corpus luteum ist durch ein streng reguliertes System von miteinander kommunizierenden Zellen, den lutealen Steroidhormon-produzierenden Zellen und den Endothelzellen, geprägt. Diese Zell-Zell-Kommunikation ermöglicht die Kontrolle von Neoangiogenese, die für die Entstehung des Corpus luteum Voraussetzung ist, und deren Aufgabe die rasche Freigabe von großen Mengen Progesteron ins Blutgefäßsystem ist. Voraussetzung für diesen Vorgang ist die hormonelle Regulation der Endothelzellproliferation sowie der Gefäßpermeabilität durch LH und hCG. Das morphologische Korrelat der endothelialen Permeabilität sind Zell-Zell-Adhäsionsmoleküle wie Adherens Junctions (AJ) und Tight Junctions (TJ), die „reißverschlussartig“ den Spalt benachbarter interagierender Endothelzellen öffnen und schließen. Im Corpus luteum konnten verschiedene Zell-Adhäsionsmoleküle nachgewiesen werden, darunter Occludin, Claudin 1 und Claudin 5 sowie VE-Cadherin. Es ist davon auszugehen, dass die Regulation von AJ- und TJ-Proteinen von besonderer Bedeutung für die Permeabilität und damit die Funktionalität des Corpus luteum in der Frühschwangerschaft ist, da hCG-Behandlung zu einer Herunterregulation der Zell-Adhäsionsmoleküle in den Lutealgefäßen führt. Offensichtlich ist dieser Effekt VEGF-vermittelt. Funktionell betrachtet führt die hCG-abhängige und VEGF-vermittelte Herunterregulation von Zelladhäsionsmolekülen zu einer verminderten Durchlässigkeit der Zell-Zell-Kontakte und damit zu gesteigerter endothelialer Permeabilität. Dabei werden die verschiedenen Zell-Adhäsionsmoleküle nicht nur direkt durch VEGF reguliert, sondern sie interagieren auch untereinander und beeinflussen sich auf diese Weise gegenseitig.


  • Open Access

    Local Renin-Angiotensin System in the Reproductive System

    by Daniel Herr, Inga Bekes, Christine Wulff

    The renin–angiotensin system (RAS) is well known as regulator of electrolytes and blood pressure. Besides this function, there are numerous studies supporting the idea of a local tissue RAS. This system controls the local activity of the different RAS family members, especially of the functional proteins Angiotensin II and Angiotensin (1-7). Those antagonistically acting proteins have been described to be expressed in different organ systems including the human reproductive tract. Therefore, this local RAS has been suspected to be involved in the control and regulation of physiological and pathological conditions in the female reproduction tract. This review of the available literature summarizes the physiological influence of the RAS on the follicular development, ovarian angiogenesis and placental- and uterine function. In addition, in the second part the role of the RAS concerning ovarian- and endometrial cancer becomes elucidated. This section includes possible novel therapeutic strategies via inhibition of RAS-mediated tumor growth and angiogenesis. Looking at a very complex system of agonistic and antagonistic tissue factors, it may be supposed that the RAS in the female reproduction tract will be of rising scientific interest in the upcoming years.


  • Antikörper und Tyrosinkinaseinhibitoren

    by D. Herr, I. Bekes, R. Kreienberg

  • Lymphangiosis carcinomatosa (LVSI) beim frühen Zervixkarzinom

    by D. Herr, R. Kreienberg, C. Kurzeder


  • Prognostic Impact of Satellite-Lymphovascular Space Involvement in Early-Stage Cervical Cancer

    by Daniel Herr, Jochem König, Volker Heilmann, Karin Koretz, Rolf Kreienberg, Christian Kurzeder

    Currently the prognostic value of lymphovascular space involvement (LVSI) in patients with cervical cancer is unclear. We evaluated the prognostic impact of different categories of LVSI on overall survival (OAS) and disease-free survival (DFS) in a Middle-European population of women with surgically staged, early cervical cancer. The records of 281 women with clinically and histologically diagnosed early cervical cancer undergoing primary surgical treatment at the University of Ulm School of Medicine between 1992 and 2006 were retrospectively reviewed. LVSI as determined by hematoxylin–eosin staining was topographically categorized as conjoined-LVSI and satellite-LVSI. The effect of LVSI, tumor stage, lymph node metastases, and histology on OAS and DFS was assessed by Cox regression analyses. Tumor size and nodal status could be confirmed as significant prognostic factors for OAS and DFS in early-stage cervical cancer. While no significant effect of LVSI in general (satellite-LVSI or conjoined-LVSI) on OAS and DFS was calculated, the presence of satellite-LVSI was associated with significant decreased rates of both, OAS and DFS. We propose satellite-LVSI as new risk factor for patients with early-stage cervical cancer, in order to better identify the patients urgently needing adjuvant therapy.


  • hCG‐dependent regulation of angiogenic factors in human granulosa lutein cells

    by B. Phan, A. Rakenius, D. Pietrowski, H. Bettendorf, C. Keck, D. Herr

    As prerequisite for development and maintenance of many diseases angiogenesis is of particular interest in medicine. Pathologic angiogenesis takes place in chronic arthritis, collagen diseases, arteriosclerosis, retinopathy associated with diabetes, and particularly in cancers. However, angiogenesis as a physiological process regularly occurs in the ovary. After ovulation the corpus luteum is formed by rapid vascularization of initially avascular granulosa lutein cell tissue. This process is regulated by gonadotropic hormones. In order to gain further insights in the regulatory mechanisms of angiogenesis in the ovary, we investigated these mechanisms in cell culture of human granulosa lutein cells. In particular, we determined the expression and production of several angiogenic factors including tissue inhibitor of matrix metalloproteinases‐1 (TIMP‐1), Leptin, connective tissue growth factor (CTGF), meningioma‐associated complimentary DNA (Mac25), basic fibroblast growth factor (bFGF), and Midkine. In addition, we showed that human chorionic gonadotropin (hCG) has distinct effects on their expression and production. hCG enhances the expression and production of TIMP‐1, whereas it downregulates the expression of CTGF and Mac25. Furthermore it decreases the expression of Leptin. Our results provide evidence that hCG determines growth and development of the corpus luteum by mediating angiogenic pathways in human granulosa lutein cells. Hence we describe a further approach to understand the regulation of angiogenesis in the ovary. Mol. Reprod. Dev.